In summary, we provide in vitro and in vivo evidence that AR signaling positively promotes RCC progression by enhancing recruitment of ECs to RCC, which may occur by modulation of AKT → NF-κB → CXCL5 signaling. The gene discussed is AKT1; the disease is renal cell carcinoma.